Yasmin Lawyer – Yasmin Birth Control under Scrutiny

Yasmin Birth control drug is the latest drug to come under scrutiny. Yasmin has been associated with several serious side effects including stroke, heart attack and even death.  Women a history involving cardiovascular problems should be especially careful.

Other severe side effects include:

• Severe allergic reactions including :rash, hives, itching, difficulty breathing.
• Tightness in the chest swelling of the mouth, face, lips, or tongue.
• Fainting
• Irregular heartbeat
• Symptoms of liver problems
• Unusual or severe vaginal bleeding
• Unusual tiredness or weakness
• vaginal irritation or discharge
• Vision changes (eg, sudden vision loss, double vision)

If you experience any of these Yasmin side effects you should seek medical attention immediatly.

Yasmin Lawyers are also investigating these reports and are looking for women who may have severe side effects from yasmin birth control.

For more information call our free legal hotline 1-866-242-0905

Raptiva Box Warning

Raptiva Box Warning -Efalizumab Box Warning

The FDA notified healthcare professionals of extensive labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including bacterial sepsis, viral meningitis, invasive fungal disease, progressive multifocal leukoencephalopathy and other opportunistic infections with the use of Raptiva.

In addition, the prescribing information will be updated to describe a potential risk for the permanent suppression of the immune system with repeat administration of Raptiva in children. Raptiva is not approved for children under 18 years of age.

Raptiva is prescribed for Psoriasis which is a skin disease that is caused, in part, by an overactive immune system.

Raptiva is administered once a week, as an injection under the skin (also called a subcutaneous injection). If you will be giving the injection to yourself or another person, the doctor will instruct you on how to prepare and inject the medication.

The usual sites for injection are the upper leg, upper arm, abdomen, or buttocks. The injection site should be rotated each week. Do not change the dose or stop taking Raptiva without first talking to your doctor.

Doctors and other prescribers should carefully evaluate and weigh the risk/benefit profile of Raptiva for patients who would be more susceptible to these risks. Health care professionals should monitor patients treated with Raptiva for the signs and symptoms of these adverse events and also instruct patients to report any such signs and symptoms to them without delay.

Patients identified to begin therapy with Raptiva should have received all their age-appropriate vaccinations before starting the drug.

Patients with pre-existing infections or who have a compromised immune system should notify their health care professional before beginning treatment with Raptiva.

Spiriva Study – Possible Risk of Heart Attacks

The blockbuster inhaled lung medication Spiriva , marketed by Pfizer Inc and Boehringer Ingelheim, raises the risk of heart attack, stroke and death from heart disease, researchers said on Tuesday.

People who took Spiriva or Boehringer’s older medication, Atrovent, for at least a month were 58 percent more likely to experience heart attack, stroke or cardiovascular death than those taking other drugs, the U.S. researchers wrote in the Journal of the American Medical Association.

Germany’s privately held Boehringer Ingelheim and Pfizer said they strongly disagreed with the study’s conclusions.

Via -(Reuters)